Is Solesence, Inc. Common Stock (SLSN) a Buy, Sell, or Hold?
NASDAQ : SLSN
Solesence, Inc. Common Stock
$1.035 USD
-$0.04 (-3.27%)
- Volume
- 40.36K
- Average Volume
- 85.63K
- Market Capitalization
- $73.1M
- P/E Ratio
- 67.65
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.55
- Year Low
- $0.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.08
Company Overview
NASDAQ
Kevin Cureton
Household & Personal Products
Consumer Defensive
SLSN
115
US
USD
Liquidity Metrics
1.31
2.08
0.70
0.05
0.00
Sales & Valuation
$62.06M
1.21
4.31
-21.14
-0.05
Profitability
$0.02
$1.79M
1.56%
1.68%
5.39%
1.98%
P/E Metrics
67.65
-0.97
-0.97
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
0.31
5/9
$13.72M
$47.79M
$30.83M
$2.03M
Key Metrics (TTM)
$97.29M
1.61
32.26
2.08
5.39%
1.91%
1.25%
-4.58%
$0.27
145 days
Company Executives
| Name | Title |
|---|---|
| Laura Riffner | Chief Financial Officer |
| Kevin Cureton | President, CEO & Director |
Poll Results
No votes yet today — be the first to share your view!
About Solesence, Inc. Common Stock (NASDAQ:SLSN) Stock
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection. ...
Solésence Reschedules Second Quarter 2026 Conference Call to August 19
2026-08-10 18:15:00
ROMEOVILLE, Ill. , Aug. 10, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has rescheduled its second quarter 2026 conference call and webcast.
Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
2026-07-28 16:10:00
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.
SLSN Unveils Two Scalp Care Products Using Patented Technology
2026-07-14 12:51:09
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.
Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
2026-07-13 08:30:00
New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen
2026-06-18 15:49:00
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.
2026-05-19 15:31:49
SPF-Infused Concealer Featuring Kleair, WHSPR, and Chromalüm Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin ROMEOVILLE, Ill. , May 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that its prototype product, Day Mode Hero Concealer SPF 50, has won across three prototype product/chassis categories at the 2026 Cosmetics and Toiletries (C&T) Allē Awards: Anti-Aging, Color Cosmetics, and Compromised Skin.
2026-05-19 15:31:00
SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
2026-05-19 14:50:10
Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.
Frequently Asked Questions
-
What is the current Solesence, Inc. Common Stock (SLSN) stock price?
-
Solesence, Inc. Common Stock(NASDAQ:SLSN) stock price is $1.035 in the last trading session. During the trading session, SLSN stock reached the peak price of $4.55 while $0.61 was the lowest point it dropped to. The percentage change in SLSN stock occurred in the recent session was --3.27% while the dollar amount for the price change in SLSN stock was -$0.04.
-
SLSN's industry and sector of operation?
-
The NASDAQ listed SLSN is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector.
-
Who are the executives of SLSN?
-
Laura Riffner | Chief Financial Officer
Kevin Cureton | President, CEO & Director
|
|
| -
How many employees does SLSN have?
-
Number of SLSN employees currently stands at 115. SLSN operates from 1319 Marquette Drive, Romeoville, IL 60446, US.
-
Link for SLSN official website?
-
Official Website of SLSN is: https://solesence.com
-
How do I contact SLSN?
-
SLSN could be contacted at phone #1 (630) 771-6078 and can also be accessed through its website. SLSN operates from 1319 Marquette Drive, Romeoville, IL 60446, US.
-
How many shares of SLSN are traded daily?
-
The average number of SLSN shares traded daily for last 3 months was 85.63K.
-
What is the market cap of SLSN currently?
-
The market value of SLSN currently stands at $73.1M with its latest stock price at $1.035